// App-Quantinova.ai

TCT-322 : The Smokers Paradox Revisited: A 5-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials

Researchers

Presenter

  • Mayank Yadav

Principal Investigators

  • Philippe Genereux

  • Bjorn Redfors

  • Mahesh Madhavan

  • Ajay Kirtane

  • Rupa Parvataneni

  • Gregg Stone

Medical Centers

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Cardiovascular Research Foundation, New York, United States

  • Columbia University Medical Center/Hopital du Sacre-Coeur de Montreal, New York, New York, United States

  • CRF, south richmond hill, New York, United States

  • Newyork Presbyterian Hospital, Newyork, New York, United States

  • CUMC, New York, New York, United States

  • Newyork Presbyterian Hospital, Newyork, New York, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • TAXUS

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim